| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 59.15B | 60.47B | 53.79B | 47.35B | 59.18B | 43.62B |
| Gross Profit | 13.21B | 13.24B | 11.77B | 10.81B | 10.16B | 9.25B |
| EBITDA | 5.92B | 6.03B | 5.66B | 4.27B | 4.52B | 3.48B |
| Net Income | 3.52B | 3.64B | 3.55B | 2.38B | 2.33B | 1.78B |
Balance Sheet | ||||||
| Total Assets | 70.63B | 67.44B | 67.89B | 64.00B | 64.29B | 58.76B |
| Cash, Cash Equivalents and Short-Term Investments | 9.37B | 6.52B | 8.35B | 6.99B | 8.76B | 7.41B |
| Total Debt | 18.70B | 13.98B | 17.02B | 11.44B | 13.70B | 9.21B |
| Total Liabilities | 32.38B | 28.52B | 30.14B | 25.91B | 27.81B | 22.28B |
| Stockholders Equity | 38.24B | 38.90B | 37.75B | 38.08B | 36.47B | 36.48B |
Cash Flow | ||||||
| Free Cash Flow | 2.56B | 3.17B | -2.20B | -82.00M | -2.11B | 351.00M |
| Operating Cash Flow | 3.04B | 5.30B | -739.00M | 1.10B | -1.10B | 1.48B |
| Investing Cash Flow | -347.50M | -1.76B | -1.04B | 826.00M | -830.00M | -338.00M |
| Financing Cash Flow | -3.32B | -5.42B | 3.12B | -3.72B | 3.21B | -5.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | €35.34B | 10.12 | 9.76% | 4.87% | 0.60% | -23.08% | |
76 Outperform | ¥53.03B | 11.66 | ― | 2.81% | 2.85% | 3.17% | |
75 Outperform | ¥49.43B | 5.34 | 13.58% | 1.17% | 6.01% | 49.59% | |
74 Outperform | ¥55.29B | 21.76 | 1.99% | 4.23% | 30.99% | -65.52% | |
72 Outperform | ¥39.96B | 9.53 | ― | 3.48% | 18.47% | 64.23% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥49.35B | 14.08 | ― | 3.25% | 6.35% | -34.20% |